Shanghai Xingqi EMI Biotechnology Co., Ltd.

Established by U.S. returned scholars, the company is mainly engaged in the development and production of nucleic acid delivery technology and related products, and is one of the most domestic companies with nucleic acid delivery technology.The series of transplant reagents is suitable for different cell characteristics, siRNA delivery efficiency, gene elimination efficiency, cell toxicity is significantly superior to the international first-line brand; plasma DNA transplant positive rate, reorganization protein expression is significantly superior to the domestic and foreign first-line brand.The relevant technology has been granted domestic patent license.